Vasodepressor phospholipids in reversal of renal hypertension.
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000818:Animals; D000959:Antihypertensive Agents / Q000378:metabolism; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001794:Blood Pressure; D015232:Dinoprostone; D006978:Hypertension, Renovascular / Q000503:physiopathology*; D010741:Phospholipases A / Q000378:metabolism; D010743:Phospholipids / Q000502:physiology*; D010972:Platelet Activating Factor / Q000031:analogs & derivatives / Q000502:physiology; D011458:Prostaglandins E / Q000652:urine; D051381:Rats
D000959:Antihypertensive Agents; D001095:Arachidonic Acids; C029271:O-deacetyl platelet activating factor; D010743:Phospholipids; D010972:Platelet Activating Factor; D011458:Prostaglandins E; D016718:Arachidonic Acid; D015121:6-Ketoprostaglandin F1 alpha; D010741:Phospholipases A; D015232:Dinoprostone